Related Experiment Video

Updated: Nov 3, 2025

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients
13:50

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients

Published on: June 11, 2011

12.4K

Long-coronavirus disease among people living with HIV in western India: An observational study

Sanjay Pujari1, Sunil Gaikwad1, Abhishek Chitalikar1

  • 1Institute of Infectious Diseases, Pune, India.

Immunity, Inflammation and Disease
|June 2, 2021
PubMed

Insights

Long-COVID is prevalent in people living with HIV (PLHIV), especially after moderate-severe COVID-19. Integrating long-COVID care into HIV clinics is crucial for this population.

Area of Science:

  • Infectious Diseases
  • Public Health
  • HIV Medicine

Background:

  • Long-COVID presents a growing health challenge for individuals recovering from COVID-19.
  • Limited data exists on the prevalence, characteristics, and risk factors of long-COVID among people living with HIV (PLHIV).

Purpose of the Study:

  • To investigate the prevalence and identify risk factors for long-COVID in people living with HIV.
  • To understand the clinical presentation and symptom duration of long-COVID in this specific cohort.

Main Methods:

  • A prospective, observational study conducted at a tertiary HIV clinic in India.
  • Screening of 94 PLHIV using a questionnaire for long-COVID symptoms (present >30 days post-illness onset).
  • Logistic regression analysis to determine risk factors associated with long-COVID development.

Main Results:

  • The prevalence of long-COVID among PLHIV was 43.6%.
  • Moderate-to-severe acute COVID-19 illness was a significant risk factor (aOR 4.7, p=0.016).
  • Common symptoms included cough and fatigue; persistent symptoms were noted in 10.6% of cases.

Conclusions:

  • Long-COVID is common in PLHIV, particularly those with moderate-to-severe COVID-19.
  • Integration of long-COVID diagnosis and care into antiretroviral therapy clinics is recommended for PLHIV.
Abstract

Keywords:
HIVIndialong-COVIDprevalencerisk factors

More Related Videos

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays13:58

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays

Published on: September 26, 2011

31.8K
Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

16.0K

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
444
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
563
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
778
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
287
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.8K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.7K